HT
ELV icon

HAP Trading’s Elevance Health ELV Stock Holding History

HAP Trading’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-101,400
Closed -$33K – 1745
2020
Q1 		$33K Buy
101,400
+6,000
+6% +$1.64M ﹤0.01% 845
2019
Q4 		$14K Sell
95,400
-200
-0.2% -$55K ﹤0.01% 953
2019
Q3 		$31K Sell
95,600
-39,800
-29% -$10.9M ﹤0.01% 845
2019
Q2 		$524K Buy
135,400
+39,500
+41% +$10.8M 0.04% 329
2019
Q1 		$654K Buy
+95,900
New +$27.7M 0.06% 243
2018
Q4 		– Sell
-70,300
Closed -$904K – 1163
2018
Q3 		$904K Sell
70,300
-100
-0.1% -$26K 0.06% 227
2018
Q2 		$295K Buy
+70,400
New +$16.3M 0.01% 406
2014
Q3 		– Sell
-270,100
Closed -$5.79M – 1045
2014
Q2 		$5.79M Buy
+270,100
New +$27.8M 0.21% 96

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

HAP Trading's ELV Position: Q2 2020 in Review

HAP Trading sold out of Elevance Health (ELV) in Q2 2020, closing a stake of 62,579 shares — an estimated $16.7M sold.

HAP Trading first reported a position in ELV in Q2 2013 and held it in 7 quarters. The position peaked at $39.2M in Q1 2014. 1,107 funds tracked by Wall St. Rank hold ELV as of Q2 2020.

  • HAP Trading reported no remaining Elevance Health position as of Q2 2020 after selling out during the quarter.
  • HAP Trading sold 62,579 Elevance Health shares in Q2 2020, an estimated $16.7M.
  • HAP Trading first reported a position in Elevance Health in Q2 2013 and held it in 7 quarters.
  • HAP Trading's Elevance Health position peaked at $39.2M in Q1 2014.
  • 1,107 funds tracked by Wall St. Rank held Elevance Health as of Q2 2020.

Based on HAP Trading's 13F filing for Q2 2020, filed 10 Aug 2020.